Immunoforge

Immunoforge is a drug development company for the treatment of sarcopenia and cancer. The company has a solution based on sarcopenia, its drug repurposing patent, and a robust pipeline of kinase inhibitors for genomically defined rare cancers, such as chronic myeloid leukemia, which can lead to patient cures.